Prognostic effect of residual plasma Epstein-Barr viral DNA after induction chemotherapy for locoregionally advanced nasopharyngeal carcinoma.
Hua ZhengPing ZhouXiu-Bei ChenYi-Feng YuRui ZhouQin LinSan-Gang WuPublished in: Cancer medicine (2023)
-EBV DNA may be a robust indicator to identify the optimal candidate for intensive treatment.